Literature DB >> 28497395

Cardioprotective effects of Qishen Granule () on sarcoplasmic reticulum Ca2+ handling in heart failure rats.

Ling-Hui Lu1, Chun Li2, Qi-Yan Wang3, Qian Zhang1, Yi Zhang2,4, Hui Meng2,4, Yong Wang3, Wei Wang5.   

Abstract

OBJECTIVE: To assess the effects of Qishen Granule (, QSG) on sarcoplasmic reticulum (SR) Ca2+ handling in heart failure (HF) model of rats and to explore the underlying molecular mechanisms.
METHODS: HF rat models were induced by left anterior descending coronary artery ligation surgery and high-fat diet feeding. Rats were randomly divided into sham (n=10), model (n=10), QSG (n=12, 2.2 g/kg daily) and metoprolol groups (n=12, 10.5 mg/kg daily). The therapeutic effects of QSG were evaluated by echocardiography and blood lipid testing. Intracellular Ca2+ concentration and sarco-endoplasmic reticulum ATPase 2a (SERCA2a) activity were detected by specifific assay kits. Expressions of the critical regulators in SR Ca2+ handling were evaluated by Western blot and real-time quantitative polymerase chain reaction.
RESULTS: HF model of rats developed ventricular remodeling accompanied with calcium overload and defective Ca2+ release-uptake cycling in cardiomyocytes. Treatment with QSG improved contractive function, attenuated ventricular remodeling and reduced the basal intracellular Ca2+ level. QSG prevented defective Ca2+ leak by attenuating hyperphosphorylation of ryanodine receptor 2, inhibiting expression of protein kinase A and up-regulating transcriptional expression of protein phosphatase 1. QSG also restored Ca2+ uptake by up-regulating expression and activity of SERCA2a and promoting phosphorylation of phospholamban.
CONCLUSION: QSG restored SR Ca2+ cycling in HF rats and served as an ideal alternative drug for treating HF.

Entities:  

Keywords:  Ca2+ handling; Chinese medicine; Qishen Granule; heart failure; ryanodine receptor 2; sarco-endoplasmic reticulum ATPase 2a

Mesh:

Substances:

Year:  2017        PMID: 28497395     DOI: 10.1007/s11655-017-2809-x

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  31 in total

Review 1.  Acute Coronary Syndromes: Unstable Angina and Non-ST Elevation Myocardial Infarction.

Authors:  Sukhdeep S Basra; Salim S Virani; David Paniagua; Biswajit Kar; Hani Jneid
Journal:  Heart Fail Clin       Date:  2016-01       Impact factor: 3.179

2.  Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.

Authors:  Ralph J van Oort; Mark D McCauley; Sayali S Dixit; Laetitia Pereira; Yi Yang; Jonathan L Respress; Qiongling Wang; Angela C De Almeida; Darlene G Skapura; Mark E Anderson; Donald M Bers; Xander H T Wehrens
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

Review 3.  Optimal Use of Beta-Blockers for Congestive Heart Failure.

Authors:  Hae-Young Lee; Sang Hong Baek
Journal:  Circ J       Date:  2016-02-19       Impact factor: 2.993

Review 4.  Metabolic support for the heart: complementary therapy for heart failure?

Authors:  Ward A Heggermont; Anna-Pia Papageorgiou; Stephane Heymans; Marc van Bilsen
Journal:  Eur J Heart Fail       Date:  2016-11-04       Impact factor: 15.534

5.  Cardiotonic modulation in heart failure: insights from traditional Chinese medicine.

Authors:  W H Wilson Tang; Yanming Huang
Journal:  J Am Coll Cardiol       Date:  2013-06-07       Impact factor: 24.094

6.  Normalizing the metabolic phenotype after myocardial infarction: impact of subchronic high fat feeding.

Authors:  Jessica M Berthiaume; Martin E Young; Xiaoqin Chen; Tracy A McElfresh; Xin Yu; Margaret P Chandler
Journal:  J Mol Cell Cardiol       Date:  2012-04-20       Impact factor: 5.000

Review 7.  The ryanodine receptor in cardiac physiology and disease.

Authors:  Alexander Kushnir; Andrew R Marks
Journal:  Adv Pharmacol       Date:  2010

8.  Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Steven Reiken; John A Vest; Anetta Wronska; Andrew R Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-06       Impact factor: 11.205

9.  Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2.

Authors:  Yong Wang; Chun Li; Yulin Ouyang; Junda Yu; Shuzhen Guo; Zhongyang Liu; Dong Li; Jing Han; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-13       Impact factor: 2.629

Review 10.  SERCA2a: a prime target for modulation of cardiac contractility during heart failure.

Authors:  Woo Jin Park; Jae Gyun Oh
Journal:  BMB Rep       Date:  2013-05       Impact factor: 4.778

View more
  5 in total

1.  A Network Pharmacology Approach to Explore the Mechanisms of Qishen Granules in Heart Failure.

Authors:  Junjie Liu; Yuan Li; Yili Zhang; Mengqi Huo; Xiaoli Sun; Zixuan Xu; Nannan Tan; Kangjia Du; Yong Wang; Jian Zhang; Wei Wang
Journal:  Med Sci Monit       Date:  2019-10-15

2.  Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway.

Authors:  Jian Zhang; Junjie Liu; Sheng Gao; Weili Lin; Pengrong Gao; Kuo Gao; Yili Zhang; Kangjia Du; Xiaomin Yang; Wei Wang; Ruixin Zhu; Yong Wang
Journal:  Biomed Res Int       Date:  2019-12-12       Impact factor: 3.411

3.  Decomposing the Mechanism of Qishen Granules in the Treatment of Heart Failure by a Quantitative Pathway Analysis Method.

Authors:  Weiquan Ren; Sheng Gao; Huimin Zhang; Yinglu Ren; Xue Yu; Weili Lin; Shuzhen Guo; Ruixin Zhu; Wei Wang
Journal:  Molecules       Date:  2018-07-23       Impact factor: 4.411

4.  Qishen granules exerts cardioprotective effects on rats with heart failure via regulating fatty acid and glucose metabolism.

Authors:  Kuo Gao; Jian Zhang; Pengrong Gao; Qiyan Wang; Ying Liu; Junjie Liu; Yili Zhang; Yan Li; Hong Chang; Ping Ren; Jinmin Liu; Yong Wang; Wei Wang
Journal:  Chin Med       Date:  2020-03-04       Impact factor: 5.455

5.  Efficacy and safety of Qishen granules for chronic heart failure: A protocol for systematic review and meta-analysis.

Authors:  Junjie Liu; Zixuan Xu; Shuangjie Yang; Kangjia Du; Yili Zhang; Nannan Tan; Xiaoli Sun; Huihui Zhao; Wei Wang
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.